Literature DB >> 20721690

Clinical significance of a serum CA 15-3 surge and the usefulness of CA 15-3 kinetics in monitoring chemotherapy response in patients with metastatic breast cancer.

Shih-Chung Wu, Fong-Fu Chou, Kun-Ming Rau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20721690     DOI： 10.1007/s10549-010-1117-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  4 in total

Review 1.  Current approaches and challenges in monitoring treatment responses in breast cancer.

Authors:  Lindsey J Graham; Matthew P Shupe; Erika J Schneble; Frederick L Flynt; Michael N Clemenshaw; Aaron D Kirkpatrick; Chris Gallagher; Aviram Nissan; Leonard Henry; Alexander Stojadinovic; George E Peoples; Nathan M Shumway
Journal:  J Cancer       Date:  2014-01-05       Impact factor: 4.207

2.  Aberrant reduction of telomere repetitive sequences in plasma cell-free DNA for early breast cancer detection.

Authors:  Xi Wu; Hiromi Tanaka
Journal:  Oncotarget       Date:  2015-10-06

3.  MUC1 (CA27.29) before and after Chemotherapy and Prognosis in High-Risk Early Breast Cancer Patients.

Authors:  Hanna Huebner; Lothar Häberle; Volkmar Müller; Iris Schrader; Ralf Lorenz; Helmut Forstbauer; Visnja Fink; Fabienne Schochter; Inga Bekes; Sven Mahner; Julia Jückstock; Naiba Nabieva; Andreas Schneeweiss; Hans Tesch; Sara Y Brucker; Jens-Uwe Blohmer; Tanja N Fehm; Georg Heinrich; Mahdi Rezai; Matthias W Beckmann; Peter A Fasching; Wolfgang Janni; Brigitte Rack
Journal:  Cancers (Basel)       Date:  2022-03-28       Impact factor: 6.639

4.  Serum microRNA-155 as a potential biomarker to track disease in breast cancer.

Authors:  Yu Sun; Minjie Wang; Guigao Lin; Shipeng Sun; Xuexiang Li; Jun Qi; Jinming Li
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.